| COMPOSITION |
| Each vial contains |
| Diminazene aceturate |
1 050 mg
|
| Excipient q.s.f |
2 360 mg
|
|
INDICATIONS
Target species: cattle, buffaloes, horses, sheep, goats, dogs.
- Treatment and prevention of bebesiosis (piroplasmosis), thei-leriosis, trypanosomiasis and trichomoniasis or mixed infections with trypanosomas and piroplasmas:
● Trypanosoma: T. Congolense, T. Brucei, T. Evansi, T. Vivax.
● Babesia Bovis, B. Bigemina, B. Ovis, B. Motasi, B. Canis.
● Theileria annulata.
● Trichomonas foetus.
- The preparation is indicated also to young, weak animals and female animals in gestation.
| ADMINISTRATION AND DOSAGE |
|
Deep I.M. injection.
Dissolve each vial into 14 ml of water for injection.
- Curative dose: 3.5 mg diminazene/kg b.w
or one vial per 300 kg b.w
If necessary, the dose can be raised up to 8 mg/kg b.w, but the total single dose should not exceed 4 g/head.
- Preventive dose: 7 ml of solution/100 kg b.w
- Treatment for dogs: Dissolve the content of vial in 25 ml of water for injection and inject each 1 ml per 10 kg b.w
|
| WITHDRAWAL PERIOD: |
Meat: 21 days
|
| |
Milk: 5 days (10 milkings)
|
| SHELF-LIFE |
5 years. |
| STORAGE |
In cool, dry place, protected from light |
| PRESENTATION |
Vials of 2.36 g. |
EN
VN
